T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LDR
2276
DELISTED
Landauer Inc
LDR
| $223K | ﹤0.01% |
+5,420
| New | +$202K |
|
|
RAS
2277
DELISTED
RAIT Financial Trust
RAS
| $223K | ﹤0.01% |
71,400
+30,000
| +72% | +$91.6K |
|
2278
Photronics
PLAB
$1.98B
| $222K | ﹤0.01% |
24,960
+7,100
| +40% | +$70.5K |
|
2279
Alico
ALCO
$306M
| $221K | ﹤0.01% |
7,310
| – | – |
|
|
USAK
2280
DELISTED
USA Truck Inc
USAK
| $221K | ﹤0.01% |
12,600
| – | – |
|
|
TBI
2281
Trueblue
TBI
$304M
| $220K | ﹤0.01% |
11,610
| – | – |
|
2282
Kratos Defense & Security Solutions
KTOS
$11.9B
| $219K | ﹤0.01% |
53,377
-39,180
| -42% | -$177K |
|
|
STBZ
2283
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $218K | ﹤0.01% |
10,690
| – | – |
|
2284
AMERISAFE
AMSF
$505M
| $217K | ﹤0.01% |
+3,550
| New | +$203K |
|
2285
Pure Cycle
PCYO
$273M
| $217K | ﹤0.01% |
46,000
+31,300
| +213% | +$143K |
|
2286
TriCo Bancshares
TCBK
$1.85B
| $217K | ﹤0.01% |
7,860
-900
| -10% | -$24.3K |
|
2287
Bassett Furniture
BSET
$171M
| $216K | ﹤0.01% |
9,030
| – | – |
|
2288
Coty
COTY
$2.45B
| $216K | ﹤0.01% |
8,304
-72
| -0.9% | -$1.97K |
|
2289
Hawthorn Bancshares
HWBK
$277M
| $215K | ﹤0.01% |
+20,493
| New | +$219K |
|
2290
Lattice Semiconductor
LSCC
$18.4B
| $215K | ﹤0.01% |
40,100
| – | – |
|
|
CSII
2291
DELISTED
Cardiovascular Systems, Inc.
CSII
| $215K | ﹤0.01% |
11,700
| – | – |
|
2292
Western New England Bancorp
WNEB
$281M
| $213K | ﹤0.01% |
27,600
| – | – |
|
2293
AerCap
AER
$23.4B
| $212K | ﹤0.01% |
+6,300
| New | +$242K |
|
|
OLP
2294
One Liberty Properties
OLP
$534M
| $212K | ﹤0.01% |
+8,892
| New | +$205K |
|
2295
Agilysys
AGYS
$3.13B
| $211K | ﹤0.01% |
20,152
+9,500
| +89% | +$103K |
|
2296
Univest Financial
UVSP
$1.19B
| $211K | ﹤0.01% |
10,059
-41
| -0.4% | -$816 |
|
2297
IDT Corp
IDT
$1.66B
| $210K | ﹤0.01% |
17,476
-3,403
| -16% | -$37.7K |
|
2298
Virtus Investment Partners
VRTS
$1.14B
| $210K | ﹤0.01% |
2,944
| – | – |
|
2299
Gogo Inc
GOGO
$385M
| $209K | ﹤0.01% |
24,960
+7,600
| +44% | +$75.7K |
|
2300
Standard BioTools
LAB
$305M
| $208K | ﹤0.01% |
23,000
| – | – |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.